CRDF

Cardiff Oncology, Inc.

SCoRE: 40

LAST PRICE - AT THE CLOSE

CRDF is DOWN -36% since the begininning of the year

CRDF is DOWN -14% BELOW 20 day SMA

CRDF is DOWN -10% BELOW 200 day SMA

View More CRDF Price Action

PROFITABLE: NO
EPS: $-0.22

EARNINGS MOMENTUM: NO
0.14% DECREASE IN QTRLY EARNINGS

P/E RATIO IS: N/A
INCOME TO DEBT RATIO: 0.00

REVENUE IS: 683K

DEBT IS: 2K

CASH IS: 92M

	THE STOCK IS 89.1% AWAY FROM ALL-TIME HIGHS OF $25.5
	CRDF IS DOWN -36% SINCE THE BEGINNING OF THE YEAR
	CRDF IS DOWN -50% OVER THE PAST 12 MONTHS
	CRDF IS DOWN -30% OVER THE PAST 1 MONTH
	25% OF ALL CRDF INVESTORS ARE BETTING AGAINST CRDF
	NUM INVESTORS SHORT CRDF HAS GONE UP N/A% VERSUS LAST MONTH